AI-10-49 displays specific growth inhibition of inv(16)-positive cell line ME-1. AI-10-49 selectively binds to CBFβ-SMMHC, disrupts its binding to RUNX1, and restores RUNX1 transcriptional activity.
In vivo
In mice transplanted with Cbfb;Nras leukemic cells, AI-10-49 (200 mg/kg, i.p.) reduces leukemia expansion.